XML 55 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
REVENUES BY PRODUCT AND SERVICE CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS
9 Months Ended
Dec. 31, 2014
REVENUES BY PRODUCT AND SERVICE CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS [Abstract]  
REVENUES BY PRODUCT AND SERVICE CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS
NOTE 17.  REVENUES BY PRODUCT AND SERVICE CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS

Revenue Information

The following is a summary of our revenues by product and service category (in thousands):

  
Three Months Ended
December 31,
  
Nine Months Ended
December 31,
 
Revenues by Product and Service Category
 
2014
  
2013
  
2014
  
2013
 
Instruments(1)
 
$
19,242
  
$
8,161
  
$
36,941
  
$
30,373
 
Consumables(2)
  
34,232
   
28,096
   
106,656
   
87,394
 
Other products and services(3)
  
5,990
   
4,515
   
17,213
   
11,950
 
Product and service revenues, net
  
59,464
   
40,772
   
160,810
   
129,717
 
Development and licensing revenue
  
38
   
38
   
112
   
113
 
Total revenues
 
$
59,502
  
$
40,810
  
$
160,922
  
$
129,830
 
 

(1)Instruments include chemistry analyzers, hematology instruments, VSpro specialty analyzers and i-STAT analyzers.
(2)Consumables include reagent discs, hematology reagent kits, VSpro specialty cartridges, i-STAT cartridges and rapid tests.
(3)Other products and services include veterinary reference laboratory diagnostic and consulting services.
 
The following is a summary of our revenues by geographic region based on customer location (in thousands):

  
Three Months Ended
December 31,
  
Nine Months Ended
December 31,
 
Revenues by Geographic Region
 
2014
  
2013
  
2014
  
2013
 
North America
 
$
49,027
  
$
31,801
  
$
131,878
  
$
103,773
 
Europe
  
8,154
   
7,173
   
22,682
   
20,171
 
Asia Pacific and rest of the world
  
2,321
   
1,836
   
6,362
   
5,886
 
Total revenues
 
$
59,502
  
$
40,810
  
$
160,922
  
$
129,830
 

Significant Concentrations

During the three months ended December 31, 2014, two distributors in the United States, MWI Veterinary Supply and Abbott Point of Care, Inc., accounted for 17% and 13%, respectively, of our total worldwide revenues.  During the nine months ended December 31, 2014, two distributors in the United States, MWI Veterinary Supply and Abbott Point of Care, Inc., accounted for 17% and 10%, respectively, of our total worldwide revenues.

During the three months ended December 31, 2013, one distributor in the United States, Abbott Point of Care, Inc, accounted for 12% of our total worldwide revenues.  During the nine months ended December 31, 2013, one distributor in the United States, MWI Veterinary Supply, accounted for 18% of our total worldwide revenues.

Concentration of credit risk with respect to accounts receivable is primarily limited to certain distributors to whom we make significant sales.  One distributor in the United States accounted for 24% and 25% of our total receivable balance at December 31, 2014 and March 31, 2014, respectively.